Tromboprofilaxis en COVID-19. Nuevas evidencias
R Ferrandis, P Sierra, A Gomez-Luque - Revista Española de …, 2023 - Elsevier
Recientes publicaciones han puesto en duda la eficacia de la utilización de dosis
terapéuticas o intermedias de heparina de bajo peso molecular (HBPM) en pacientes …
terapéuticas o intermedias de heparina de bajo peso molecular (HBPM) en pacientes …
Eficacia de la tromboprofilaxis con heparina de bajo peso molecular en pacientes críticos con COVID-19: estudio observacional, prospectivo y multicéntrico
R Ferrandis, B Escontrela, C Ferrando… - Revista Española de …, 2023 - Elsevier
Introducción Los pacientes COVID-19 presentan una coagulopatía caracterizada por una
elevada incidencia de complicaciones tromboembólicas. Ante la controversia existente …
elevada incidencia de complicaciones tromboembólicas. Ante la controversia existente …
COVID-19 thromboprophylaxis. New evidence
R Ferrandis, P Sierra, A Gomez-Luque - Revista Española de …, 2023 - Elsevier
Recent publications have questioned the efficacy of using therapeutic or intermediate doses
of low molecular weight heparin in COVID-19 patients, especially in the most severe …
of low molecular weight heparin in COVID-19 patients, especially in the most severe …
Which Thromboprophylaxis Dose Gives the Best Clinical Outcomes Among Critically Ill COVID-19 Patients? A Multicenter Cohort Study
AAH Alrashed - 2023 - search.proquest.com
Introduction: Thrombotic complications of coronavirus disease 2019 (COVID-19) have
received considerable attention. Although numerous conflicting findings have compared …
received considerable attention. Although numerous conflicting findings have compared …
Guía de profilaxia y tratamiento antitrombótico para pacientes con COVID-19. Consenso del Grupo Cooperativo Latinoamericano en Hemostasia y Trombosis (CLAHT …
C Guillermo-Esposito, P Casais… - … de cardiología de …, 2021 - scielo.org.mx
La coagulopatía y la trombosis asociadas a la enfermedad por coronavirus 2019 (COVID-
19) representan un problema importante en el manejo de esta enfermedad. Los estudios …
19) representan un problema importante en el manejo de esta enfermedad. Los estudios …
Thromboprophylaxis in hospitalized Non-Critically ill patients with mild-to-Moderate COVID-19 infection: a systematic review and Meta-Analysis
A Hafiz, H Alkofide, K Al Sulaiman… - Clinical and Applied …, 2023 - journals.sagepub.com
The prevalence of venous thromboembolism is high in patients with COVID-19, despite
prophylactic anticoagulation. The evidence that supports the preferred thromboprophylaxis …
prophylactic anticoagulation. The evidence that supports the preferred thromboprophylaxis …
Effectiveness of thromboprophylaxis with low molecular weight heparin in critically ill patients with COVID-19. An observational prospective, multicenter study
R Ferrandis, B Escontrela, C Ferrando… - Revista Española de …, 2023 - Elsevier
Introduction COVID-19 induces coagulopathy associated with an increase of
thromboembolic events. Due to the lack of agreement on recommendations for …
thromboembolic events. Due to the lack of agreement on recommendations for …
Thromboprophylaxis in hospitalized COVID-19 patients: the efficacy and safety of the approved hospital protocol.
E Kolanko, T Senderek… - Polish Archives of …, 2021 - europepmc.org
Introduction: Prothrombotic coagulopathy in COVID-19 has led to a strong recommendation
for thromboprophylaxis in all hospitalized patients, although there are large differences in …
for thromboprophylaxis in all hospitalized patients, although there are large differences in …
Low in-hospital mortality rate in patients with COVID-19 receiving thromboprophylaxis: data from the multicentre observational START-COVID Register
D Poli, E Antonucci, W Ageno, P Prandoni… - Internal and emergency …, 2022 - Springer
COVID-19 infection causes respiratory pathology with severe interstitial pneumonia and
extra-pulmonary complications; in particular, it may predispose to thromboembolic disease …
extra-pulmonary complications; in particular, it may predispose to thromboembolic disease …
High versus standard intensity of thromboprophylaxis in hospitalized patients with COVID-19: a systematic review and meta-analysis
Thromboprophylaxis in hospitalized patients with COVID-19 has been associated with a
survival benefit and is strongly recommended. However, the optimal dose of …
survival benefit and is strongly recommended. However, the optimal dose of …